Picton Mahoney Asset Management’s Aspire Biopharma Holdings, Inc. Warrant ASBPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
50,000
| – | – | ﹤0.01% | 934 |
|
|
2025
Q1 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 647 |
|
|
2024
Q4 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 548 |
|
|
2024
Q3 | $1K | Hold |
50,000
| – | – | ﹤0.01% | 808 |
|
|
2024
Q2 | $1K | Hold |
50,000
| – | – | ﹤0.01% | 574 |
|
|
2024
Q1 | $1K | Hold |
50,000
| – | – | ﹤0.01% | 345 |
|
|
2023
Q4 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 399 |
|
|
2023
Q3 | $3K | Hold |
50,000
| – | – | ﹤0.01% | 379 |
|
|
2023
Q2 | $3K | Sell |
50,000
-25,000
| -33% | -$1.5K | ﹤0.01% | 394 |
|
|
2023
Q1 | $3K | Hold |
75,000
| – | – | ﹤0.01% | 458 |
|
|
2022
Q4 | $5K | Hold |
75,000
| – | – | ﹤0.01% | 579 |
|
|
2022
Q3 | $9K | Hold |
75,000
| – | – | ﹤0.01% | 629 |
|
|
2022
Q2 | $12K | Buy |
+75,000
| New | +$12K | ﹤0.01% | 726 |
|